Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 99.5M | 91.0M | 83.8M | 94.2M |
| Cost of revenue | 36.9M | 44.1M | 31.7M | 34.1M |
| Gross profit | 62.6M | 46.8M | 52.1M | 60.1M |
| Operating expense | ||||
| Research & development | 11.8M | 10.9M | 10.7M | 12.9M |
| Selling general and admin | 38.1M | 38.4M | 37.6M | 39.3M |
| Other operating expenses | — | — | — | — |
| Operating income | 12.7M | -2.5M | 3.8M | 7.9M |
| Non operating interest income | ||||
| Income | 2.5M | 2.8M | 2.7M | 2.9M |
| Expense | 1.1M | 1.1M | 1.0M | 940K |
| Other income expense | — | — | — | — |
| Pretax income | 18.5M | 1.5M | 5.1M | 16.6M |
| Tax provision | 4.3M | 1.7M | 2.0M | 4.1M |
| Net income | 14.2M | -185K | 3.0M | 12.4M |
| Basic EPS | 0.2 | — | 0.1 | 0.2 |
| Diluted EPS | 0.2 | — | 0.1 | 0.2 |
| Basic average shares | 86.6M | — | 82M | 86.3M |
| Diluted average shares | 86.6M | — | 82M | 86.3M |
| EBITDA | 40.0M | 19.7M | 25.7M | 33.3M |
| Net income from continuing op. | 18.5M | 1.5M | 5.1M | 16.6M |
| Minority interests | 2.3M | 2.3M | 2.7M | 2.2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |